SCHEMBL5318211

SCHEMBL5318211

OCCCC=Cc1nn(Cc2ccc(Cl)cc2Cl)c2cc(C(F)(F)F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 2/20 0.40
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
PMP22 Q01453 1/20 0.39
HIF1A Q16665 1/20 0.39
PPARG P37231 3/20 0.36
NPC1 O15118 1/20 0.35
SLC9A1 P19634 1/20 0.34
LMNA P02545 2/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GLA P06280 1/20 0.34
HPGD P15428 1/20 0.34
SLC22A12 Q96S37 1/20 0.34
MAPT P10636 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5318209 1.00 ENPP2 (0.40) ENPP2NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL5316361 0.94 ENPP2 (0.41) ENPP2NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL5316363 0.94 ENPP2 (0.41) ENPP2NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL5317765 0.91 NR1H2 (0.40) ENPP2CYP2C9SLC22A12AKR1B1NR1H2
SCHEMBL5317768 0.91 NR1H2 (0.40) ENPP2CYP2C9SLC22A12AKR1B1NR1H2
SCHEMBL5319914 0.91 NR1H2 (0.39) ENPP2PPARGLMNASLC22A12NR1H2
SCHEMBL5319915 0.91 NR1H2 (0.39) ENPP2PPARGLMNASLC22A12NR1H2
SCHEMBL5318742 0.91 ENPP2 (0.39) ENPP2NPSR1CYP2C9PPARGSLC22A12
SCHEMBL5318741 0.91 ENPP2 (0.39) ENPP2NPSR1CYP2C9PPARGSLC22A12
SCHEMBL1045413 0.90 ENPP2 (0.42) ENPP2NPSR1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed